SIGHT SCIENCES, INC. Operating Expenses
SIGHT SCIENCES, INC. (SGHT) reported Operating Expenses of $25.26 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:OperatingExpenses · last filed 2026-08-05
- SIGHT SCIENCES, INC. operating expenses for the quarter ending 2026-06-30 was $25.26M, a 10.59% decline year-over-year.
- SIGHT SCIENCES, INC. operating expenses for the quarter ending 2026-03-31 was $29.39M, a 1.51% increase year-over-year.
- SIGHT SCIENCES, INC. operating expenses for the quarter ending 2025-12-31 was $21.46M, a 24.69% decline year-over-year.
- SIGHT SCIENCES, INC. operating expenses for the quarter ending 2025-09-30 was $25.10M, a 10.78% decline year-over-year.
- SIGHT SCIENCES, INC. operating expenses for fiscal 2025 was $103.77M, a 12.67% decline from fiscal 2024.
- SIGHT SCIENCES, INC. operating expenses for fiscal 2024 was $118.82M, a 6.04% decline from fiscal 2023.
- SIGHT SCIENCES, INC. operating expenses for fiscal 2023 was $126.45M, a 11.53% decline from fiscal 2022.
- SIGHT SCIENCES, INC. operating expenses for fiscal 2022 was $142.92M, a 55.65% increase from fiscal 2021.
| Period end | Operating Expenses 3 month | Operating Expenses 6 month | Operating Expenses 9 month | Operating Expenses 12 month |
|---|---|---|---|---|
| 2026-06-30 | $25.26M 10-Q · filed 2026-08-05 | $54.65M 10-Q · filed 2026-08-05 | $76.11M derived: sum of 3 quarters · filed 2026-08-05 | $101.21M derived: sum of 4 quarters · filed 2026-08-05 |
| 2026-03-31 | $29.39M 10-Q · filed 2026-05-06 | $50.85M derived: sum of 2 quarters · filed 2026-05-06 | $75.95M derived: sum of 3 quarters · filed 2026-05-06 | $104.20M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-12-31 | $21.46M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-04 | $46.56M derived: sum of 2 quarters · filed 2026-03-04 | $74.81M derived: sum of 3 quarters · filed 2026-08-05 | $103.77M 10-K · filed 2026-03-04 |
| 2025-09-30 | $25.10M 10-Q · filed 2025-11-06 | $53.36M derived: sum of 2 quarters · filed 2026-08-05 | $82.31M 10-Q · filed 2025-11-06 | $110.80M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-06-30 | $28.25M 10-Q · filed 2026-08-05 | $57.21M 10-Q · filed 2026-08-05 | $85.70M derived: sum of 3 quarters · filed 2026-08-05 | $113.83M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-03-31 | $28.95M 10-Q · filed 2026-05-06 | $57.44M derived: sum of 2 quarters · filed 2026-05-06 | $85.58M derived: sum of 3 quarters · filed 2026-05-06 | $116.58M derived: sum of 4 quarters · filed 2026-05-06 |
| 2024-12-31 | $28.49M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-04 | $56.63M derived: sum of 2 quarters · filed 2026-03-04 | $87.62M derived: sum of 3 quarters · filed 2026-03-04 | $118.82M 10-K · filed 2026-03-04 |
| 2024-09-30 | $28.14M 10-Q · filed 2025-11-06 | $59.13M derived: sum of 2 quarters · filed 2025-11-06 | $90.33M 10-Q · filed 2025-11-06 | $117.41M derived: sum of 4 quarters · filed 2025-11-06 |
| 2024-06-30 | $31.00M 10-Q · filed 2025-08-07 | $62.19M 10-Q · filed 2025-08-07 | $89.28M derived: sum of 3 quarters · filed 2025-08-07 | $120.02M derived: sum of 4 quarters · filed 2025-08-07 |
| 2024-03-31 | $31.20M 10-Q · filed 2025-05-08 | $58.28M derived: sum of 2 quarters · filed 2025-05-08 | $89.02M derived: sum of 3 quarters · filed 2025-05-08 | $124.30M derived: sum of 4 quarters · filed 2025-05-08 |
| 2023-12-31 | $27.09M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-07 | $57.83M derived: sum of 2 quarters · filed 2025-03-07 | $93.11M derived: sum of 3 quarters · filed 2025-03-07 | $126.45M 10-K · filed 2025-03-07 |
| 2023-09-30 | $30.74M 10-Q · filed 2024-11-07 | $66.02M derived: sum of 2 quarters · filed 2024-11-07 | $99.36M 10-Q · filed 2024-11-07 | $133.29M derived: sum of 4 quarters · filed 2024-11-07 |
| 2023-06-30 | $35.28M 10-Q · filed 2024-08-02 | $68.62M 10-Q · filed 2024-08-02 | $102.55M derived: sum of 3 quarters · filed 2024-08-02 | $140.15M derived: sum of 4 quarters · filed 2024-08-02 |
| 2023-03-31 | $33.34M 10-Q · filed 2024-05-06 | $67.28M derived: sum of 2 quarters · filed 2024-05-06 | $104.87M derived: sum of 3 quarters · filed 2024-05-06 | $142.23M derived: sum of 4 quarters · filed 2024-05-06 |
| 2022-12-31 | $33.93M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-13 | $71.53M derived: sum of 2 quarters · filed 2024-03-13 | $108.88M derived: sum of 3 quarters · filed 2024-03-13 | $142.92M 10-K · filed 2024-03-13 |
| 2022-09-30 | $37.59M 10-Q · filed 2023-11-07 | $74.95M derived: sum of 2 quarters · filed 2023-11-07 | $108.99M 10-Q · filed 2023-11-07 | $136.45M derived: sum of 4 quarters · filed 2023-11-07 |
| 2022-06-30 | $37.36M 10-Q · filed 2023-08-07 | $71.40M 10-Q · filed 2023-08-07 | $98.86M derived: sum of 3 quarters · filed 2023-08-07 | $123.93M derived: sum of 4 quarters · filed 2023-08-07 |
| 2022-03-31 | $34.04M 10-Q · filed 2023-05-08 | $61.50M derived: sum of 2 quarters · filed 2023-05-08 | $86.57M derived: sum of 3 quarters · filed 2023-05-08 | $107.88M derived: sum of 4 quarters · filed 2023-05-08 |
| 2021-12-31 | $27.46M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-16 | $52.53M derived: sum of 2 quarters · filed 2023-03-16 | $73.83M derived: sum of 3 quarters · filed 2023-03-16 | $91.82M 10-K · filed 2023-03-16 |
| 2021-09-30 | $25.07M 10-Q · filed 2022-11-10 | $46.38M derived: sum of 2 quarters · filed 2022-11-10 | $64.36M 10-Q · filed 2022-11-10 | $79.41M derived: sum of 4 quarters · filed 2022-11-10 |
| 2021-06-30 | $21.31M 10-Q · filed 2022-08-11 | $39.30M 10-Q · filed 2022-08-11 | $54.34M derived: sum of 3 quarters · filed 2022-08-11 | $67.73M derived: sum of 4 quarters · filed 2022-08-11 |
| 2021-03-31 | $17.99M 10-Q · filed 2022-05-10 | $33.04M derived: sum of 2 quarters · filed 2022-05-10 | $46.42M derived: sum of 3 quarters · filed 2022-05-10 | $55.53M derived: sum of 4 quarters · filed 2022-05-10 |
| 2020-12-31 | $15.05M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-24 | $28.43M derived: sum of 2 quarters · filed 2022-03-24 | $37.54M derived: sum of 3 quarters · filed 2022-03-24 | $50.62M 10-K · filed 2022-03-24 |
| 2020-09-30 | $13.39M 10-Q · filed 2021-11-10 | $22.49M derived: sum of 2 quarters · filed 2021-11-10 | $35.57M 10-Q · filed 2021-11-10 | |
| 2020-06-30 | $9.11M 10-Q · filed 2021-08-12 | $22.18M 10-Q · filed 2021-08-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NeuroPace Inc (NPCE) | United States | $0.480B | -28.52 |
| ClearPoint Neuro, Inc. (CLPT) | United States | $0.446B | -15.74 |
| TACTILE SYSTEMS TECHNOLOGY INC (TCMD) | United States | $0.519B | 27.16 |
| CERUS CORP (CERS) | United States | $0.525B | -86.40 |
| CARLSMED, INC. (CARL) | United States | $0.405B | |
| DELCATH SYSTEMS, INC. (DCTH) | United States | $0.558B | 820.33 |
| Orthofix Medical Inc. (OFIX) | $0.373B | ||
| SS Innovations International, Inc. (SSII) | $0.589B | -64.06 | |
| ORTHOPEDIATRICS CORP (KIDS) | United States | $0.592B | |
| Orchestra BioMed Holdings, Inc. (OBIO) | United States | $0.356B | -4.39 |